Therefore, we propose that ZEB1 deletion in stromal fibroblasts reduces the secretion of these pro-tumourigenic signalling molecules to the surrounding stroma, thus suppressing mammary tumour growth and progression in a paracrine fashion. Here, ZEB1 is linked to breast cancer.